Literature DB >> 22278249

Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle.

Grant S Hansman1, David W Taylor, Jason S McLellan, Thomas J Smith, Ivelin Georgiev, Jeremy R H Tame, Sam-Yong Park, Makoto Yamazaki, Fumio Gondaira, Motohiro Miki, Kazuhiko Katayama, Kazuyoshi Murata, Peter D Kwong.   

Abstract

Human noroviruses are genetically and antigenically highly divergent. Monoclonal antibodies raised in mice against one kind of norovirus virus-like particle (VLP), however, were found to have broad recognition. In this study, we present the crystal structure of the antigen-binding fragment (Fab) for one of these broadly reactive monoclonal antibodies, 5B18, in complex with the capsid-protruding domain from a genogroup II genotype 10 (GII.10) norovirus at 3.3-Å resolution and, also, the cryo-electron microscopy structure of the GII.10 VLP at ∼10-Å resolution. The GII.10 VLP structure was more similar in overall architecture to the GV.1 murine norovirus virion than to the prototype GI.1 human norovirus VLP, with the GII.10 protruding domain raised ∼15 Å off the shell domain and rotated ∼40° relative to the GI.1 protruding domain. In the crystal structure, the 5B18 Fab bound to a highly conserved region of the protruding domain. Based on the VLP structure, this region is involved in interactions with other regions of the capsid and is buried in the virus particle. Despite the occluded nature of the recognized epitope in the VLP structure, enzyme-linked immunosorbent assay (ELISA) binding suggested that the 5B18 antibody was able to capture intact VLPs. Together, the results provide evidence that the norovirus particle is capable of extreme conformational flexibility, which may allow for antibody recognition of conserved surfaces that would otherwise be buried on intact particles.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278249      PMCID: PMC3302548          DOI: 10.1128/JVI.06868-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  71 in total

1.  Large conformational changes in the maturation of a simple RNA virus, nudaurelia capensis omega virus (NomegaV).

Authors:  M A Canady; M Tihova; T N Hanzlik; J E Johnson; M Yeager
Journal:  J Mol Biol       Date:  2000-06-09       Impact factor: 5.469

2.  High-resolution x-ray structure and functional analysis of the murine norovirus 1 capsid protein protruding domain.

Authors:  Stefan Taube; John R Rubin; Umesh Katpally; Thomas J Smith; Ann Kendall; Jeanne A Stuckey; Christiane E Wobus
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: recognition of a novel conformational epitope.

Authors:  Tomoyuki Shiota; Michio Okame; Sayaka Takanashi; Pattara Khamrin; Makiko Takagi; Kenji Satou; Yuichi Masuoka; Fumihiro Yagyu; Yuko Shimizu; Hideki Kohno; Masashi Mizuguchi; Shoko Okitsu; Hiroshi Ushijima
Journal:  J Virol       Date:  2007-09-12       Impact factor: 5.103

4.  Evidence of viral capsid dynamics using limited proteolysis and mass spectrometry.

Authors:  B Bothner; X F Dong; L Bibbs; J E Johnson; G Siuzdak
Journal:  J Biol Chem       Date:  1998-01-09       Impact factor: 5.157

5.  Probability analysis of variational crystallization and its application to gp120, the exterior envelope glycoprotein of type 1 human immunodeficiency virus (HIV-1).

Authors:  P D Kwong; R Wyatt; E Desjardins; J Robinson; J S Culp; B D Hellmig; R W Sweet; J Sodroski; W A Hendrickson
Journal:  J Biol Chem       Date:  1999-02-12       Impact factor: 5.157

6.  Norwalk virus infection of volunteers: new insights based on improved assays.

Authors:  D Y Graham; X Jiang; T Tanaka; A R Opekun; H P Madore; M K Estes
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

7.  Evaluation of a commercial ELISA for detecting Norwalk-like virus antigen in faeces.

Authors:  A F Richards; B Lopman; A Gunn; A Curry; D Ellis; H Cotterill; S Ratcliffe; M Jenkins; H Appleton; C I Gallimore; J J Gray; D W G Brown
Journal:  J Clin Virol       Date:  2003-01       Impact factor: 3.168

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  Conformational alteration of Sindbis virion glycoproteins induced by heat, reducing agents, or low pH.

Authors:  W J Meyer; S Gidwitz; V K Ayers; R J Schoepp; R E Johnston
Journal:  J Virol       Date:  1992-06       Impact factor: 5.103

10.  The P domain of norovirus capsid protein forms dimer and binds to histo-blood group antigen receptors.

Authors:  Ming Tan; Rashmi S Hegde; Xi Jiang
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  48 in total

1.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Nanobody-Mediated Neutralization Reveals an Achilles Heel for Norovirus.

Authors:  Anna D Koromyslova; Jessica M Devant; Turgay Kilic; Charles D Sabin; Virginie Malak; Grant S Hansman
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

3.  Characterization of blockade antibody responses in GII.2.1976 Snow Mountain virus-infected subjects.

Authors:  Jesica Swanstrom; Lisa C Lindesmith; Eric F Donaldson; Boyd Yount; Ralph S Baric
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

4.  Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.

Authors:  Sue E Crawford; Nadim Ajami; Tracy Dewese Parker; Noritoshi Kitamoto; Katsuro Natori; Naokazu Takeda; Tomoyuki Tanaka; Baijun Kou; Robert L Atmar; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

5.  Characterization of cross-reactive norovirus-specific monoclonal antibodies.

Authors:  Baijun Kou; Sue E Crawford; Nadim J Ajami; Rita Czakó; Frederick H Neill; Tomoyuki N Tanaka; Noritoshi Kitamoto; Timothy G Palzkill; Mary K Estes; Robert L Atmar
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

6.  Production of Human Norovirus Protruding Domains in E. coli for X-ray Crystallography.

Authors:  Mila M Leuthold; Anna D Koromyslova; Bishal K Singh; Grant S Hansman
Journal:  J Vis Exp       Date:  2016-04-19       Impact factor: 1.355

7.  Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.

Authors:  Brigitte Fiege; Mila Leuthold; Francisco Parra; Kevin P Dalton; Peter J Meloncelli; Todd L Lowary; Thomas Peters
Journal:  Glycoconj J       Date:  2017-08-19       Impact factor: 2.916

8.  Structural basis for norovirus neutralization by an HBGA blocking human IgA antibody.

Authors:  Sreejesh Shanker; Rita Czakó; Gopal Sapparapu; Gabriela Alvarado; Maria Viskovska; Banumathi Sankaran; Robert L Atmar; James E Crowe; Mary K Estes; B V Venkataram Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

9.  Bile Salts Alter the Mouse Norovirus Capsid Conformation: Possible Implications for Cell Attachment and Immune Evasion.

Authors:  Michael B Sherman; Alexis N Williams; Hong Q Smith; Christopher Nelson; Craig B Wilen; Daved H Fremont; Herbert W Virgin; Thomas J Smith
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

10.  Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Authors:  Jackie E Mahar; Nicole C Donker; Karin Bok; Gert H Talbo; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.